SWI/SNF-compromised cancers are susceptible to bromodomain inhibitors

T Shorstova, M Marques, J Su, J Johnston… - Cancer research, 2019 - AACR
The antitumor activity of bromodomain and extraterminal motif protein inhibitors (BETi) has
been demonstrated across numerous types of cancer. As such, these inhibitors are currently …
被引用次数：65 相关文章

SWI/SNF-Compromised Cancers Are Susceptible to Bromodomain Inhibitors.

T Shorstova, M Marques, J Su, J Johnston… - Cancer …, 2019 - europepmc.org
The antitumor activity of bromodomain and extraterminal motif protein inhibitors (BETi) has
been demonstrated across numerous types of cancer. As such, these inhibitors are currently …

SWI/SNF-Compromised Cancers Are Susceptible to Bromodomain Inhibitors

T Shorstova, M Marques, J Su, J Johnston… - Cancer …, 2019 - pubmed.ncbi.nlm.nih.gov
The antitumor activity of bromodomain and extraterminal motif protein inhibitors (BETi) has
been demonstrated across numerous types of cancer. As such, these inhibitors are currently …
[PDF] researchgate.net

[PDF][PDF] SWI/SNF-compromised cancers are susceptible to bromodomain inhibitors

T Shorstova, M Marques, J Su, J Johnston… - researchgate.net
The antitumor activity of bromodomain and extra-terminal motif protein inhibitors (BETi) has
been demonstrated across numerous types of cancer. As such, these inhibitors are currently …